Magellan Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-854
Closed -$29K 85
2017
Q3
$29K Hold
854
﹤0.01% 76
2017
Q2
$27K Hold
854
﹤0.01% 76
2017
Q1
$0 Hold
854
﹤0.01% 83
2016
Q4
$26K Buy
+854
New +$26.1K ﹤0.01% 75

Other funds holding PFE

Magellan Asset Management's PFE Position: Q4 2017 in Review

Magellan Asset Management sold out of Pfizer (PFE) in Q4 2017, closing a stake of 854 shares — an estimated $29K sold.

Magellan Asset Management first reported a position in PFE in Q4 2016 and held it in 4 quarters. The position peaked at $29K in Q3 2017. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Magellan Asset Management reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Magellan Asset Management sold 854 Pfizer shares in Q4 2017, an estimated $29K.
  • Magellan Asset Management first reported a position in Pfizer in Q4 2016 and held it in 4 quarters.
  • Magellan Asset Management's Pfizer position peaked at $29K in Q3 2017.
  • 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Magellan Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.